Received Jan 29, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE) | SANOFI PASTEUR | UNK | — | — |
feel itching on hands after the back rash was cleared; Severe full back rash; This is a spontaneous report received from an Other HCP. Other Case identifier(s): 2025SA388135 (Sanofi). A 79-year-old male patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 11Oct2024 as dose 1, single (Batch/Lot number: unknown) at the age of 79 years for covid-19 immunisation; influenza vaccine inact split 3v (FLUZONE HIGH DOSE), on 11Oct2024 as dose number unknown, single for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RASH (non-serious) with onset 08Nov2024, outcome "recovered", described as "Severe full back rash"; PRURITUS (non-serious), outcome "unknown", described as "feel itching on hands after the back rash was cleared". The event "feel itching on hands after the back rash was cleared" required physician office visit. Therapeutic measures were taken as a result of rash, pruritus. Additional information: On 08Nov2024 the patient had severe full back rash. On an unknown date the patient feel itching on hands after the back rash was cleared. It was reported that, "Patient went to visit a dermatologist and was prescribed Pills for the itching." Corrective treatment included Steroid for the event (rash). At time of reporting, the outcome was Recovered/Resolved on an unknown date for the event rash and was Unknown for the event pruritus. Case seriousness reported as Non-serious. Company (Sanofi) causality was reported as related. Batch/lot number is not provided, and it cannot be obtained.